Observations on the "cascade" of Na-K-ATPase inhibitory and digoxin-like immunoreactive material in human urine: possible relevance to essential hypertension.
Previous investigations have demonstrated an increased amount of a sodium pump inhibitor (N.H.) in plasma from humans with essential hypertension and from animals with various forms of experimental hypertension. The present study has employed Sephadex column and C18 reverse phase separation of urines from patients with essential hypertension and normal controls to distinguish "high", "intermediate" and "low" molecular weight forms of N.H., measured through properties of Na-K-ATPase inhibition and digoxin-like immunoreactivity. The major difference between hypertensive and normotensive urines was a highly significant increase in the "intermediate" molecular weight form of N.H., as measured by Na-K-ATPase inhibition. In contrast, digoxin-like immunoreactivity was significantly decreased in urine from hypertensive patients. The results are compatible with an hypothesis that the defect in some forms of essential hypertension may be partial inhibition of enzymatic conversion of intermediate to final form of N.H., with the increased sodium pump inhibition primarily related to the precursor.
D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D004077:Digoxin / Q000652:urine*; D006801:Humans; D006973:Hypertension / Q000652:urine*; D008954:Models, Biological; D008970:Molecular Weight; D011506:Proteins; D011507:Proteinuria; D000097795:ATPase Inhibitory Protein
D004077:Digoxin; D011506:Proteins; D000097795:ATPase Inhibitory Protein